Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnosis and Treatment Technologies for Severe Acute High Altitude Disease
NCT07639931Not yet recruiting
- Sponsor
- People's Hospital of Tibet Autonomous Region
- Start
- Jul 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Open-label trial of nitric oxide in high altitude pulmonary edema (HAPE) and cerebral edema (10 arms), sponsored by People's Hospital of Tibet Autonomous Region. Primary endpoints: HAPE Recovery at 36 months, HACE Recovery at 36 months and 2 more. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
nitric oxide
03
Conditions
high altitude pulmonary edema (HAPE)cerebral edema
Beyond the preview
Go deeper on NCT07639931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07639931.